BBOTVSBTAI• 7 Days (Normalized)
BBOT vs BTAI (BridgeBio Oncology Therapeutics Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Sep 25 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-1.52%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
BTAI Performance $0
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
-1.52 pts
BTAI outperforming by 1.52 percentage points
BBOTBTAI
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | BBOT Price | BBOT Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -1.52% | $- | - | |
| Sep 30, 2026 | $4.10 | +3.80% | $- | - | |
| Sep 29, 2026 | $3.92 | -0.76% | $- | - | |
| Sep 28, 2026 | $3.81 | -3.54% | $- | - | |
| Sep 25, 2026 | $3.95 | +0.00% | $- | - |